Application no. and date | 18728514.3 (espacenet) (Federated) (European Patent Register), 20180426 | Patent/reg. no. and date | DK/EP 3615541, 20250319 | Publication date | 20200304 | Priority no. and date | US 201762491812 P, 20170428 | EP pub. no. and date |
EP 3615541 20200304 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | | Inventor | CHAKRAVARTY, Paroma, c/o Genentech Inc. 1 DNA Way
South San Francisco California 94080, US, HAN, Chong, c/o Genentech Inc. 1 DNA Way
South San Francisco California 94080, US, KELLY, Sean M., c/o Genentech Inc. 1 DNA Way
South San Francisco California 94080, US, NAGAPUDI, Karthik, c/o Genentech Inc. 1 DNA Way
South San Francisco California 94080, US, SAVAGE, Scott, 545 Middlefield Rd. Suite 208
Menlo Park California 94025, US | Representative | | Opponent | | IPC Class | A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , C07B 63/00 (2006.01) , C07D 498/04 (2006.01) | Title | POLYMORPHS AND SOLID FORMS OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMIDE, AND METHODS OF PRODUCTION | Int. application no. | EP2018060820 | Int. publication no. | WO2018197653 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|